Ip Group Regulatory News (IPO)

IP Group - Investor webinar

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property-based businesses, is pleased to announce that it will be hosting a webinar on the role that science and innovation has to play in building resilience in health systems.

The webinar, which will take place on Thursday 29 October at 16:00GMT, will feature short presentations from Dr Gordon Sanghera, CEO of portfolio company Oxford Nanopore Technologies, and Hugh Lloyd-Jukes, CEO of portfolio company Oxehealth, detailing how their companies have innovated in the battle against the pandemic.

IP Group is committed to clear and open communication with stakeholders and attendees will have the opportunity to ask questions as part of the event. For more details or to register as a participant please visit https://www.ipgroupplc.com/events.

No material new information will be released by the Company during the webinar.

For more information, please contact:

Notes for editors

About IP Group

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com.

ENDS